Topic
Life Sciences
News
Clinical TrialsGeneral Science & ResearchLaboratoryLife Sciences
Oncolytics Biotech appoints chief scientific officer
December 9, 2004 by Lab Canada Calgary, AB – Oncolytics Biotech has appointed Dr Matt Coffey as chief scientific officer. Dr Coffey was formerly the company’s vice president of product development. Oncolytics is developing a formulation of the human reovirus as a potential cancer therapeutic. It…
News
Clinical TrialsLaboratoryLife Sciences
LAB International to initiate phase II trial for GHRH
December 8, 2004 by Lab Canada Laval, AC – Drug development company LAB International says that, after completion of a successful dose-response trial, it has selected the first clinical indication for which it intends to evaluate the efficacy of its Growth Hormone Releasing Hormone (GHRH) analogue.…
News
Clinical TrialsGeneral Science & ResearchLaboratoryLife Sciences
Pre-clinical cancer study receives NRC funding
December 6, 2004 by Lab Canada Edmonton, AB – CV Technologies says it is launching a pre-clinical study to investigate the effects of CVT-E002 in treating immune deficiency related cancers as part of its ongoing strategy to develop natural therapeuticals for disease prevention and health maintenance.…
News
Clinical TrialsLaboratoryLife Sciences
Stem cell mobilizer holds hope for potential use in allogeneic transplant for cancer patients
December 6, 2004 by Lab Canada Vancouver, BC – AnorMED has announced preliminary results on AMD3100, its lead drug candidate for stem cell transplantation, which support its potential use as a single agent to mobilize stem cells from healthy donors for allogeneic stem cell transplantation in…
News
General Science & ResearchLaboratoryLife Sciences
High-performance computer part of $1M grant to cancer research
December 6, 2004 by Lab Canada Toronto, ON – IBM has awarded a grant of a high-performance computer to researchers at the Ontario Cancer Institute to help them understand how various proteins interact with each other – a crucial step in understanding cancer progression, potentially impacting…
News
General Science & ResearchLaboratoryLife Sciences
Neurosciences institute selects brain star for the year
November 29, 2004 by Lab Canada Ottawa, ON – Queen’s University graduate, Dr Jeffrey Coull, has won the Institute of Neurosciences, Mental Health and Addiction’s Brain Star of the Year Award. Awarded each year to a promising young researcher, the award recognizes the excellence of research…
News
General Science & ResearchLaboratoryLife Sciences
Neuroscience Canada awards $4.5 million to three Canadian brain repair research teams
November 26, 2004 by Lab Canada Ottawa, ON – Three grants of $1.5 million each have been awarded for the study of brain repair. Each team will receive an additional $60,000 over three years for networking. Building on the knowledge that the brain has an innate…
News
General Science & ResearchLaboratoryLife Sciences
Health research awards salute Canadian researchers
November 25, 2004 by Lab Canada Ottawa, ON – Four health science researchers and three organizations in the field have received prestigious awards from the Canadian Institutes of Health Research. These awards are synonymous with exceptional, internationally recognized, cutting-edge research,” says Ujjal Dosanjh, federal minister of…
News
General Science & ResearchLaboratoryLife Sciences
Research hospitals receive up to $61M for equipment and facilities
November 22, 2004 by Lab Canada Ottawa, ON – The Canadian Foundation for Innovation has approved up to $61 million to support 12 projects at eight institutions under the new Research Hospital Fund (RHF). The announcement was made today by Dr Eliot Phillipson, president and CEO…
News
General Science & ResearchLaboratoryLife Sciences
Companies working to optimize microarray technology for splice variant analysis
November 17, 2004 by Lab Canada Palo Alto, CA and Paris, France – Instrument manufacturer Agilent Technologies and drug discovery company ExonHit Therapeutics have formed a research collaboration to combine Agilent’s microarray platform and ExonHit’s alternative RNA splicing technologies and expertise. The collaboration will explore the…
News
General Science & ResearchLaboratoryLife Sciences
World grid project hopes to tap public donations of idle computer time
November 16, 2004 by Lab Canada Armonk, NY – IBM, along with representatives of the world’s leading science, education and philanthropic organizations, today launched World Community Grid, a global humanitarian effort that applies the unused computing power of individual and business computers to help address the…
News
General Science & ResearchLaboratoryLife SciencesResearch Results
$194M creates new Canada research chairs
November 15, 2004 by Lab Canada Vancouver, BC – The federal government has awarded $194 million for 194 new Canada research chairs at universities across the country. “From health care, to the environment, to building stronger communities, the work of these Canada Research Chairs will have…
News
Clinical TrialsLaboratoryLife Sciences
Anticancer drug receives patent
November 10, 2004 by Lab Canada Toronto, ON – Biopharmaceutical company Lorus Therapeutics, that specializes in the research, development and commercialization of pharmaceutical products and technologies for the management of cancer, says that its subsidiary, GeneSense Technologies, has been allowed a patent by the Canadian Patent…
News
LaboratoryLife SciencesNew Facilities
New facilities for Apotex in $627M expansion
November 9, 2004 by Lab Canada Toronto, ON – Pharmaceutical manufacturer Apotex has officially opened expanded facilities at four of its Toronto-area locations. The company says the expansion project cost $627 million and is creating 1,500 technical, scientific and engineering jobs. With the addition of the…
News
General Science & ResearchLaboratoryLife Sciences
Princess Margaret Hospital receives record $25M donation
October 25, 2004 by Lab Canada Toronto, ON – Today, Canada’s leading cancer hospital announced receiving a gift of $25-million to the hospital’s newly launched Institute for Breast Cancer Research. Marking the country’s largest private gift to cancer research – and to breast cancer research –…
News
General Science & ResearchLaboratoryLife Sciences
Neurogenesis Biotech changes name to Stem Cell Therapeutics
October 25, 2004 by Lab Canada Calgary, AB – Biotech company Neurogenesis Biotech has changed its name to Stem Cell Therapeutics. The company is developing therapies to treat significant medical disorders by stimulating a patient’s own stem cells to enhance the body’s inherent ability for self…
News
General Science & ResearchLaboratoryLife Sciences
Biopharmaceutical company inks commercialization agreement
October 25, 2004 by Lab Canada Vancouver, BC – Protox Therapeutics says it has signed an exclusive licence agreement with Johns Hopkins University and the University of Victoria Innovation and Development Corporation. The licence grants Protox the worldwide rights to commercialize a genetically modified Aerolysin protein…
News
General Science & ResearchLaboratoryLife Sciences
New leadership team provides biotechnology expertise to the Ontario Genomics Institute
October 25, 2004 by Lab Canada Toronto, ON – Joseph Rotman, outgoing chair of the Ontario Genomics Institute (OGI) board of directors, has announced three appointments to the board. Mark Lievonen, previously an OGI director, has been appointed as the incoming chair of the board. Don…
News
LaboratoryLife SciencesResearch Results
Researchers trim count of human genes to 20,000-25,000
October 20, 2004 by Lab Canada Bethesda, Md – The International Human Genome Sequencing Consortium, led in the United States by the National Human Genome Research Institute (NHGRI) and the Department of Energy (DOE), today published its scientific description of the finished human genome sequence, reducing…
News
LaboratoryLife SciencesResearch Results
Canadian study shows pumpkins can purge pollution from contaminated soils
October 20, 2004 by Lab Canada Washington, DC – In a greenhouse study, members of the Cucurbita pepo species – including pumpkin and zucchini – demonstrated the ability to remove DDT from soil, suggesting a potential “green” technique for cleaning up sites contaminated with DDT, PCBs…
News
LaboratoryLife SciencesResearch Results
Globetrotting pollutants turn up on Toronto street
October 19, 2004 by Lab Canada Toronto, ON – Researchers at the University of Toronto have detected migratory pollutants from a forest fire in Quebec and even particles from a sandstorm in the Sahara in Toronto air, findings that could someday give regulatory agencies an idea…
News
General Science & ResearchLaboratoryLife Sciences
Combined business to develop life science research and clinical diagnostics products
October 19, 2004 by Lab Canada Chantilly, VA and Chelmsford, MA – Magellan Biosciences has acquired Dynex Technologies, a global supplier of microplate instrumentation and automation products for the biomedical research, drug discovery and clinical diagnostic markets headquartered in Chantilly, VA. Magellan acquired the Dynex business…
News
General Science & ResearchLaboratoryLife Sciences
BioMS Medical appoints drug development expert
October 14, 2004 by Lab Canada Edmonton, AB – BioMS Medical, a developer of treatments for multiple sclerosis, says it has appointed Dr Tony Verco, MBBCh, DA, to the newly created position of vice president of clinical and medical affairs. “With our lead MS drug, MBP8298,…
News
Clinical TrialsGeneral Science & ResearchLaboratoryLife Sciences
Aegera establishes a clinical advisory board
October 14, 2004 by Lab Canada Montreal, QC – Biotechnology company Aegera Therapeutics says it has established a clinical advisory board to assist in the development of its cancer and cancer-related therapeutics. “The creation of a clinical advisory board is a significant milestone in a biotech’s…
News
General Science & ResearchLaboratoryLife Sciences
Strategic alliance formed for cGMP clinical biomanufacturing
October 7, 2004 by Lab Canada Montreal, QC – Laborium Biopharma and the Biotechnology Research Institute of the National Research Council (BRI-NRC) say they have concluded a strategic alliance to offer various complementary services for manufacturing and packaging clinical lots of biological products under the stringent…
News
General Science & ResearchLaboratoryLife SciencesResearch Results
Agreement made to co-research and develop animal health products
October 1, 2004 by Lab Canada Burnaby, BC and Indianapolis, IN – Agrisoma Biosciences and Dow AgroSciences have announced a collaboration agreement to research, develop and commercialize animal health products using Agrisoma’s patented ACE system. Under the terms of the agreement, Agrisoma will apply its gene…
News
General Science & ResearchLaboratoryLife SciencesResearch Results
FDA grants fast track status for BLP25 Liposome vaccine
October 1, 2004 by Lab Canada Edmonton, AB – Biotech firm Biomira and pharmaceutical/chemical company Merck say that the US Food & Drug Administration (FDA) has granted fast track status to the investigation of BLP25 Liposome vaccine (L-BLP25) for its proposed use in the treatment of…
News
General Science & ResearchLaboratoryLife Sciences
Council urges action on HR issues in biotech sector
October 1, 2004 by Lab Canada Ottawa, ON – A new study looking at human resources in Canada’s biotech sector concludes that more attention should be paid to strengthening leadership and management in order to take biotech companies from discovery to commercialization. Biotechnology underpins many of…
News
General Science & ResearchLaboratoryLife Sciences
Young women scientists sweep major national award
September 27, 2004 by Lab Canada Toronto, ON – September 27, 2004 – Young Canadian women appear to be dominating the leading-edge science of biotechnology. Martha Mullally is the latest winner and fifth woman to receive the Young Scientist Footsteps Award, a national science award sponsored…
News
General Science & ResearchLaboratoryLife SciencesResearch Results
$6.8 million investment to double Toronto cancer patients in clinical trials
September 24, 2004 by Lab Canada Toronto, ON – September 24, 2004 – The number of patients taking part in cancer clinical trials in Toronto will double over the next three years as a result of $6.8 million in funding announced today by the Ontario Cancer…
News
General Science & ResearchLaboratoryLife SciencesResearch Results
Prostate cancer research foundation announces expanded partnership with plastics association
September 24, 2004 by Lab Canada Toronto, ON – September 24, 2004 – The Prostate Cancer Research Foundation of Canada says it has formed a partnership with the Canadian Plastics Industry Association (CPIA). This partnership will involve the CPIA broadening its previous 10-year partnership with the…
News
General Science & ResearchLaboratoryLife Sciences